DK2391641T3 - Lactobacillus rhamnosus pili og pilus polypeptider - Google Patents

Lactobacillus rhamnosus pili og pilus polypeptider Download PDF

Info

Publication number
DK2391641T3
DK2391641T3 DK10703916.6T DK10703916T DK2391641T3 DK 2391641 T3 DK2391641 T3 DK 2391641T3 DK 10703916 T DK10703916 T DK 10703916T DK 2391641 T3 DK2391641 T3 DK 2391641T3
Authority
DK
Denmark
Prior art keywords
thr
ala
leu
gly
peptide
Prior art date
Application number
DK10703916.6T
Other languages
English (en)
Inventor
Vos Willem Meindert De
Airi Palva
Justus Reunanen
Ossowski Ingemar Von
Reetta Satokari
Satu Vesterlund
Matti Kankainen
Tuomas Salusjärvi
Soile Tynkkynen
Ilkka Palva
Original Assignee
Valio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI20090031A external-priority patent/FI122200B/fi
Priority claimed from US12/364,128 external-priority patent/US8445426B2/en
Application filed by Valio Ltd filed Critical Valio Ltd
Application granted granted Critical
Publication of DK2391641T3 publication Critical patent/DK2391641T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/335Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/142Amino acids; Derivatives thereof
    • A23K20/147Polymeric derivatives, e.g. peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1285Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Corynebacterium (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Food Science & Technology (AREA)
  • Rheumatology (AREA)
  • Mycology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Child & Adolescent Psychology (AREA)

Claims (19)

1. Isoleret peptid omfattende en sekvens som har mindst 95% sekvensidentitet med SEQ ID NO 4 (GG00444).
2. Isoleret pilusstruktur omfattende peptidet ifølge krav 1.
3. Peptid eller pilusstruktur ifølge krav 1 eller 2, som er rekombinant.
4. Peptid eller pilusstruktur ifølge et hvilket som helst af de foregående krav, som er fra bakterie, grampositiv bakterie, Lactobacillus rhamnosus eller Lactobacillus rhamnosus GG (LGG) -stamme.
5. Peptid eller pilusstruktur ifølge et hvilket som helst af de foregående krav, som binder sig til fordøjelseskanalen og/eller til slimet.
6. Produkt omfattende det isolerede peptid eller den isolerede pilusstruktur ifølge et hvilket som helst af kravene 1-5.
7. Produkt ifølge krav 6, som er et levnedsmiddelprodukt, et foderprodukt eller en farmaceutisk sammensætning.
8. Produkt ifølge krav 7, hvor produktet er et levnedsmiddelprodukt, som er valgt fra gruppen bestående af mejeriprodukter, bageriprodukter, chokolade og konfekture, sukker- og gummikonfekture, kornprodukter, snacks, bær- eller frugtbaserede produkter og drikkevarer, heriblandt mælk, surmælk, yoghurt, ost og smørepålæg, mælkepulver, børnemad, babymad, småbarnsmad, modermælkserstatning, juice og suppe.
9. Produkt omfattende det isolerede peptid eller den isolerede pilusstruktur ifølge et hvilket som helst af kravene 1- 5 til anvendelse som et lægemiddel.
10. Produkt omfattende peptidet eller pilusstrukturen ifølge et hvilket som helst af kravene 1-5 til forebyggelse eller behandling af diarre, arteriel hypertension, karsygdomme, allergier, cancer, atopiske sygdomme, virussygdom, infektionssygdom, urinrørsinfektion, luftvejsinfektion, tandkaries, tyktarmskatar, kronisk tarmbetændelse, slimhindeinflammation, tarmpermeabilitetssygdom, fedme, metabolisk syndrom, oxidativt stress eller mavesmerter.
11. Polynukleotid omfattende sekvensen af SEQ ID NO 12 eller som koder for peptidet ifølge et hvilket som helst af kravene 1 og 3-5.
12. Vektor omfattende polynukleotidet ifølge krav 11.
13. Værtscelle transformeret med vektoren ifølge krav 12.
14. Genklynge som koder for peptider af en pilusstruktur og omfattende polynukleotidet ifølge krav 11.
15. Antistofsom specifikt binder peptidet ifølge et hvilket som helst af kravene 1 og 3-5, eller specifikt binder de funktionelle domæner af peptidet.
16. Peptid og/eller pilusstruktur ifølge et hvilket som helst af kravene 1-5 til at reducere eller inhibere adhæsionen af patogene bakterier til fordøjelseskanalen, til epitelet og/eller til slimet af et individ, til at fremme adhæsionen af en bakteriecelle eller et hvilket som helst andet stof til slimet eller epitelet, og/eller til at modificere immunresponset hos et individ.
17. Fremgangsmåde til fremstilling af et produkt ifølge et hvilket som helst af kravene 6-8, hvor fremgangsmåden omfatter et trin til at føje peptidet eller pilusstrukturen ifølge et hvilket som helst af kravene 1-5 til produktet.
18. Fremgangsmåde til fremstilling af peptidet ifølge et hvilket som helst af kravene 1 og 3-5, hvor fremgangsmåden omfatter de følgende trin: A) i) at tilvejebringe polynukleotidet ifølge krav 11; ii) at transformere en værtscelle med polynukleotidet; iii) at dyrke værtscellen fra trin ii) for at fremstille peptidet; iv) at genvinde peptidet, eller B) i) at tilvejebringe aminosyrer; ii) at fremstille peptidet ifølge et hvilket som helst af kravene 1 og 3-5 fra aminosyrerne fra trin i) ved syntetisering af peptidet.
19. Fremgangsmåde til fremstilling af peptidet eller pilusstrukturen ifølge et hvilket som helst af kravene 1-5, hvor fremgangsmåden omfatter de følgende trin: i) at sprænge en celle som producerer eller omfatter peptidet eller pilusstrukturen ifølge et hvilket som helst af kravene 1-5; ii) at genvinde peptidet eller pilusstrukturen.
DK10703916.6T 2009-02-02 2010-02-02 Lactobacillus rhamnosus pili og pilus polypeptider DK2391641T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20090031A FI122200B (fi) 2009-02-02 2009-02-02 Uusia peptidejä ja menetelmiä niiden valmistamiseksi
US12/364,128 US8445426B2 (en) 2009-02-02 2009-02-02 Peptides and methods for producing them
PCT/FI2010/050059 WO2010086512A2 (en) 2009-02-02 2010-02-02 Novel peptides and methods for producing them

Publications (1)

Publication Number Publication Date
DK2391641T3 true DK2391641T3 (da) 2015-02-09

Family

ID=42102292

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10703916.6T DK2391641T3 (da) 2009-02-02 2010-02-02 Lactobacillus rhamnosus pili og pilus polypeptider

Country Status (11)

Country Link
EP (1) EP2391641B1 (da)
JP (1) JP5792073B2 (da)
KR (1) KR101782170B1 (da)
CN (1) CN102317311B (da)
AU (1) AU2010209584C1 (da)
CA (1) CA2750576C (da)
DK (1) DK2391641T3 (da)
IL (1) IL214375A0 (da)
RU (1) RU2583579C2 (da)
WO (1) WO2010086512A2 (da)
ZA (1) ZA201105579B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201206599D0 (en) * 2012-04-13 2012-05-30 Univ Manchester Probiotic bacteria
CN104805043B (zh) * 2015-04-27 2017-07-04 扬州大学 一种益生菌产品中活性鼠李糖乳杆菌快速分离与计数方法
CN105699643B (zh) * 2016-03-08 2017-07-21 湖北工业大学 病原菌样本分析前预处理液及预处理方法
CN109983028B (zh) 2016-09-13 2023-10-20 英特瑞克斯顿阿克图比奥帝克斯有限公司 黏膜黏附性微生物
US20190339269A1 (en) * 2017-01-03 2019-11-07 The Trustees Of The University Of Pennsylvania Compositions and methods for predicting risk of preterm birth
KR102091175B1 (ko) * 2018-09-05 2020-04-23 서울대학교산학협력단 장내 항염증 및 균총 개선 활성을 갖는 락토바실러스 람노서스 균주
EP3866836A1 (en) * 2018-10-19 2021-08-25 Universiteit Antwerpen Anti-pathogenic activity of a bifunctional peptidoglycan/chitin hydrolase
CN113729228A (zh) * 2020-05-29 2021-12-03 安琪纽特股份有限公司 用于预防或改善腹泻的组合物及其制备方法和应用
KR20230146369A (ko) * 2022-04-12 2023-10-19 서울대학교산학협력단 신규한 미생물 및 이를 포함하는 조성물
CN115975055B (zh) * 2023-01-16 2024-02-02 四川大学 一种可在温和溶液条件下用于疫苗抗原等蛋白共价连接的新型Tag/Catcher共价连接体系
CN116486901A (zh) * 2023-05-06 2023-07-25 江苏海洋大学 基于反向疫苗学技术筛选嗜水气单胞菌保护性抗原的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
US7125698B2 (en) * 1999-08-09 2006-10-24 Matthew Glenn Polynucleotides, materials incorporating them, and methods for using them
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria

Also Published As

Publication number Publication date
AU2010209584A1 (en) 2011-08-04
ZA201105579B (en) 2012-04-25
IL214375A0 (en) 2011-09-27
KR101782170B1 (ko) 2017-09-26
WO2010086512A3 (en) 2010-09-23
CN102317311A (zh) 2012-01-11
EP2391641A2 (en) 2011-12-07
WO2010086512A2 (en) 2010-08-05
JP2012516681A (ja) 2012-07-26
RU2583579C2 (ru) 2016-05-10
JP5792073B2 (ja) 2015-10-07
CN102317311B (zh) 2015-05-27
RU2011136454A (ru) 2013-03-10
EP2391641B1 (en) 2014-12-24
KR20110114702A (ko) 2011-10-19
AU2010209584B2 (en) 2016-04-21
CA2750576C (en) 2019-02-26
AU2010209584C1 (en) 2016-09-08
CA2750576A1 (en) 2010-08-05

Similar Documents

Publication Publication Date Title
DK2391641T3 (da) Lactobacillus rhamnosus pili og pilus polypeptider
Kleerebezem et al. The extracellular biology of the lactobacilli
Henneke et al. Lipoproteins are critical TLR2 activating toxins in group B streptococcal sepsis
Corthésy et al. Cross-talk between probiotic bacteria and the host immune system1
AU2020218748B2 (en) A genetically modified lactobacillus and uses thereof
US7125698B2 (en) Polynucleotides, materials incorporating them, and methods for using them
PT1358332E (pt) Uma serpina em bifidobactérias
US6506389B2 (en) Adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors
MX2007012755A (es) Metodos y composiciones para modular la adhesion y tolerancia al estres en bacterias.
Górska et al. Identification of Lactobacillus proteins with different recognition patterns between immune rabbit sera and nonimmune mice or human sera
US8445426B2 (en) Peptides and methods for producing them
EP1394176A1 (en) Novel mucin binding polypeptides derived from Lactobacillus johnsonii
KR102016919B1 (ko) 신규한 살모넬라균 특이 박테리오파지 sc1 및 이를 포함하는 항균 조성물
JP2000505642A (ja) 非病原性微生物の新規接着因子および特定の共生的性質について微生物をスクリーニングするためのその適用;そのような微生物と接着因子とを含む新規薬剤学的組成物および食品添加物
FI122200B (fi) Uusia peptidejä ja menetelmiä niiden valmistamiseksi
KR101928898B1 (ko) 변형된 초유 단백질 및 그 어플리케이션
AU2021240230B2 (en) Vaccines and vaccine components for inhibition of microbial cells
Wen Identification and functional characterisation of a novel surface protein complex of Lactobacillus rhamnosus: a thesis presented in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Microbiology and Genetics at Massey University, Manawatu Campus, New Zealand
Hendrickx et al. Characterization of the SpaCBA Pilus